Fluorescence In-situ Hybridization (FISH) Probe Market size is projected to experience significant growth from 2019 to 2025. Growing prevalence of genetic disorders and chronic conditions such as cancer and congenital abnormalities will stimulate the growth of fluorescence in-situ hybridization business over the coming years. As per the National Cancer Institute estimates, about 1.7 million people are affected due to cancer in the U.S. annually. Thus, increasing pervasiveness of chronic and genetic disorders necessitates effective diagnosis, thereby escalating the demand of fluorescence in-situ hybridization probe technique.
Growing demand for in-vitro diagnosis and various government initiatives to support R&D activities for development of technologies and new tools will further propel industry growth. Also, various advantages associated with fluorescence in-situ hybridization probe such as high level of sensitivity and accuracy along with quick results will be conducive to business growth. Furthermore, wide array of diagnostic applications of FISH probes will positively drive the industry growth.
Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/4193
Quantitative fluorescence in-situ hybridization (Q-FISH) technique segment is expected to show significant growth across the forecast timeframe. Q-FISH technique is most commonly used to study instabilities in genome. Various advantages associated with this technique such as high specificity and affinity for telomeric repeat is the major factor associated with high demand for Q-FISH technique market growth.
RNA probes segment are forecasted to show significant growth in the future. High growth is attributed to increasing demand by various healthcare professionals for molecular profiling of various genetic disorders. Additionally, the ability of RNA probes to efficiently distinguish between various cancer subtypes will further boost segment growth. Moreover, various market players are focusing on development of advanced RNA probes to meet the growing needs, thereby fostering segmental growth in the future.
Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/4193
Use of FISH in cancer diagnosis will show significant growth across the forecast timeframe. Increasing R&D activities for exploration of various applications of FISH technique will be conducive to segment growth. Additionally, higher sensitivity of FISH as compared to other routine cytology test for cancer diagnosis will play a major growth rendering factor. Additionally, growing prevalence of breast and lung cancer in developed as well as developing countries will boost the demand for fluorescence in-situ hybridization for cancer diagnosis.
Use of FISH probes in diagnostic laboratories is expected to show significant growth in the future. High growth is attributed to increasing demand for detection of various genetic abnormalities along with diagnosis of various types of cancer and infectious diseases. Additionally, wide array of applications such as identification of novel oncogenes and gene mapping will further propel segment growth.
North America fluorescence in-situ hybridization probe market will dominate overall industry in the future owing to high adoption of advanced diagnostic techniques coupled with increasing burden of various cancer and infectious diseases. With rising prevalence of breast cancer and birth defects due to genetic disorders the adoption of FISH for diagnosis will increase, fueling the industry growth. Additionally, high selectivity, accuracy and sensitivity during diagnosis of birth defects will provide lucrative growth opportunity over the forecast period.
Asia Pacific fluorescence in-situ hybridization probe market is expected to grow at a significant pace due to various supportive government initiatives. Also, increasing focus of various market players to explore untapped opportunities in growing economies of Asia Pacific region will boost regional growth. Moreover, increasing government investments to support R&D activities and improve the healthcare infrastructure will be conducive to industry growth in the region.
Some of the major market players involved in the global fluorescence in-situ hybridization probe market are Abbott Laboratories, Abnova Corporation, Biosearch Technologies, PerkinElmer and Roche among others. Companies are implementing competitive strategies such as acquisitions and new product development to broaden their product portfolio and expansion of market share.